Hint mode is switched on Switch off

Arvinas, ordinary share
ARVN, US04335A1051

Add a stock to WL
Choose all Reset all
Arvinas, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Arvinas, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.
  • Issuer
  • Full borrower / issuer name
    Arvinas, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    ARVN
  • Placement
    27.09.2018
  • Lock up period
    180
  • Number of papers
    7,500,000
  • Volume of raised funds
    120 mln USD
  • Placement share
    23.32%
  • Final placement price
    16 USD
  • Price change since placement date
    -100%
  • By capitalization
    514.54 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    ARVN
  • Placement
    07.11.2019
  • Lock up period
    180
  • Number of papers
    4,545,455
  • Volume of raised funds
    100 mln USD
  • Placement share
    11.87%
  • Final placement price
    22 USD
  • Price change since placement date
    -60.23%
  • By capitalization
    842.47 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    ARVN
  • Placement
    16.12.2020
  • Lock up period
    180
  • Number of papers
    5,714,286
  • Volume of raised funds
    400 mln USD
  • Placement share
    12.02%
  • Final placement price
    70 USD
  • Price change since placement date
    -87.5%
  • By capitalization
    3,329.11 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

24/06/2026 Arvinas: Submission Of Matters To A Vote Of Security Holders
11/06/2026 Arvinas: Other Events
12/05/2026 Arvinas, Inc. (NASDAQ:ARVN) Q1 Earnings Beat, Revenue Miss, and Major FDA Approval
11/05/2026 Arvinas: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits
17/09/2025 Arvinas: Costs Associated With Exit Or Disposal Activities, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.